Format

Send to

Choose Destination
Oncotarget. 2016 Oct 18;7(42):68954-68965. doi: 10.18632/oncotarget.12135.

Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis.

Author information

1
Nutritional Department, the Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, China.
2
Department of Oncology, the Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, China.

Abstract

Tumor-related stroma plays an active role in tumor invasion and metastasis. The tumor-stroma ratio (TSR) in the pathologic specimen has drawn increasing attention from the field of predicting tumor prognosis. However, the prognostic value of TSR in solid tumors necessitates further elucidation. We conducted a meta-analysis on 14 studies with 4238 patients through a comprehensive electronic search on databases updated on May 2016 to explore the relationship between TSR and prognosis of solid tumors. The overall hazard ratio showed that rich stroma in tumor tissue was associated with poor overall survival (OS) (14 studies, 4238 patients) and disease-free survival (DFS) (9 studies, 2235 patients) of patients with solid tumors. The effect of low TSR on poor OS was observed among various cancer types, but not in the early stage of cervical caner. A significant relationship between low TSR and poor OS was also observed in the subgroup analyses based on study region, blinding status, and Newcastle-Ottawa Scale (NOS) score. Subgroup analyses indicated that cancer type, clinical stage, study region, blinding status, and NOS score did not affect the prognostic value of TSR for DFS. Moreover, low TSR was significantly correlated with the serious clinical stage, advanced depth of invasion, and positive lymph node metastasis. These findings indicate that a high proportion of stroma in cancer tissue is associated with poor clinical outcomes in cancer patients, and TSR may serve as an independent prognostic factor for solid tumors.

KEYWORDS:

clinicopathological features; meta-analysis; prognosis; solid tumors; tumor-stroma ratio

PMID:
27661111
PMCID:
PMC5356603
DOI:
10.18632/oncotarget.12135
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center